ClinConnect ClinConnect Logo
Search / Trial NCT05600868

The Effect of Dual Attention in an EMDR Intervention

Launched by UNIVERSIDAD COMPLUTENSE DE MADRID · Oct 26, 2022

Trial Information

Current as of September 04, 2025

Enrolling by invitation

Keywords

Trauma Traumatic Stress Disorder Emdr Dual Attention

ClinConnect Summary

The protocol will be developed following the three stages of recovery from trauma: first, focusing on establishing the therapeutic alliance and safety; second, focusing on recounting and re-processing the traumatic event; and third, focusing on reconnecting with others and with life despite the trauma experienced. This study will analyze the differences of type of traumatic processing; 1. using bilateral stimulation, 2. using fixed-point focusing and 3. closing the eyes (only exposure to the traumatic memory, without dual attention).

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Those showing a high risk of PTSD (TSQ ≥6 or TSQ ≥4 with clinical criteria) will be further evaluated to determine whether they meet the inclusion criteria. Participants must:
  • 1. Be between the ages of 18 and 65 fluent enough in Spanish language; 2.
  • Exclusion Criteria:
  • Present severe active suicidal ideation, or have made a self-injurious attempt during the last month.
  • Present a diagnosis of substance dependence, intellectual disability or severe cognitive dysfunction.
  • Participants with a score greater than or equal to 26 on the BDI-II, the inclusion of the person in the study will be assessed by clinical criteria.
  • Having received EMDR treatment in the last 6 months.
  • Also excluded from the program are those people who cannot guarantee continuity in the therapeutic process.

About Universidad Complutense De Madrid

The Universidad Complutense de Madrid (UCM) is a prestigious academic institution renowned for its commitment to research and innovation in various fields, including health sciences. As a prominent sponsor of clinical trials, UCM leverages its extensive resources and expertise to advance medical knowledge and improve patient outcomes. The university fosters collaboration among researchers, clinicians, and industry partners, ensuring the highest standards of ethics and scientific rigor in its clinical research initiatives. UCM's dedication to education and research excellence positions it as a leader in the development of new therapeutic interventions and health solutions.

Locations

Pozuelo De Alarcón, Madrid, Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials